Drug class
Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents
"Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents" is a specialized formulary and clinical classification representing systemic formulations of mast-cell stabilizing pharmaceuticals, most notably oral cromolyn sodium. Read more about Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents
8 drugs in this class 8 manufacturers
Drugs in Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents
CROMOLYN SODIUM
GASTROCROM (cromolyn sodium)
CROMOLYN SODIUM
CROMOLYN SODIUM
CROMOLYN SODIUM
GASTROCROM (cromolyn sodium)
CROMOLYN SODIUM
"Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents" is a specialized formulary and clinical classification representing systemic formulations of mast-cell stabilizing pharmaceuticals, most notably oral cromolyn sodium.
These agents function primarily by preventing antigen-induced degranulation of sensitized mast cells, thereby blocking the downstream release of potent inflammatory and allergic mediators, including histamine and leukotrienes.
Clinically, these systemic agents are primarily indicated for the management of systemic mastocytosis and other mast cell activation disorders to control gastrointestinal and systemic symptoms, as well as adjunctive long-term prophylaxis in severe refractory allergic conditions.
-
connectrx.com
"Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents" is a specialized formulary and clinical classification representing systemic formulations of mast-cell stabilizing pharmaceuticals, most notably oral cromolyn sodium Clinically, these systemic agents are primarily indicated for the management of systemic mastocytosis and other mast cell activation disorders to control gastrointestinal and systemic symptoms, as well as adjunctive long-term prophylaxis in severe refractory allergic condition...
-
nih.gov
"Mast-Cell Stabilizer-Type Anti-allergy Systemic Agents" is a specialized formulary and clinical classification representing systemic formulations of mast-cell stabilizing pharmaceuticals, most notably oral cromolyn sodium These agents function primarily by preventing antigen-induced degranulation of sensitized mast cells, thereby blocking the downstream release of potent inflammatory and allergic mediators, including histamine and leukotrienes
-
nih.gov
These agents function primarily by preventing antigen-induced degranulation of sensitized mast cells, thereby blocking the downstream release of potent inflammatory and allergic mediators, including histamine and leukotrienes
-
nih.gov
Clinically, these systemic agents are primarily indicated for the management of systemic mastocytosis and other mast cell activation disorders to control gastrointestinal and systemic symptoms, as well as adjunctive long-term prophylaxis in severe refractory allergic conditions
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.